Dr. Brian Rini is an internationally recognized leader in kidney cancer and clinical drug development and a member of the Kidney Cancer Association’s Medical Steering Committee. He recently began a new role as the inaugural Chief of Clinical Trials at Vanderbilt-Ingram Cancer Center (VICC) in Nashville, Tennessee and will continue to see patients and conduct kidney cancer research.
Four years ago, John Floyd didn’t think he’d be where he is today. At the time, wracked with a cough that had persisted for a year, he was diagnosed with stage IV renal cell carcinoma.
If you’d like to make a gift to support our research efforts in 2020, to honor or remember a loved one, or to make a gift of gratitude, visit www.kidneycancer.org/donate. 100% of every dollar you give goes directly to research!
The 20th Annual Meeting of the Society of Urologic Oncology took place in Washington, D.C. from December 4-6. Here are a few highlights from the program.
Our personal stories make us strong. But together, our voices are unstoppable. Along with over 100 other medical research and advocacy organizations, the Kidney Cancer Association co-signed the letter below and sent it to the US House and Senate leadership offices.
The KCA’s International Kidney Cancer Symposium took place on November 15-16 in Miami, Florida. Here are a few of the highlights from the program.
In honor of National Family Caregivers Month, the KCA is sharing some insights from our archives that still apply today. These tips are excerpted from the KCA’s 2012 publication We Have Kidney Cancer: Survivors Stories.
